Advanced Lung Care & Early Detection with Van Gogh by CellTivity at FirstHealth
Weston, MA – CellTivity Scientific's Van Gogh platform is setting a new standard in lung cancer diagnostics, now in use at FirstHealth and Pinehurst Medical Clinic. By enabling clinicians to observe suspicious tissue at the cellular level in real time during bronchoscopy, Van Gogh accelerates early lung cancer detection, delivers immediate biopsy results, and enhances diagnostic confidence for both patients and providers.
This breakthrough imaging technology has positioned FirstHealth as a leader in multidisciplinary lung care, driving both clinical innovation and advanced patient outcomes. Supported by a team of top pulmonologists, pathologists, and ongoing clinical trials, Van Gogh by CellTivity is transforming how lung diseases are diagnosed and managed—ushering in a new era of BioPharma excellence.
About CellTivity Scientific
CellTivity Scientific is advancing the standard of care in tissue diagnostics through real-time, metabolic assessment of biopsy samples. The Van Gogh™ Microscopy System uses Dynamic Cell Imaging™ (DCI), an advanced computational imaging algorithm that quantifies cellular metabolic activity in real time. By capturing and overlaying dynamic cellular motion on traditional morphology, DCI provides proceduralists with immediate insight into suspicions for malignancy, enabling confident decisions without compromising tissue for downstream testing.
For more information about the Van Gogh System and Dynamic Cell Imaging™, visit www.celltivity.com.
